#1 Clinical Trials Search in Europe

Flucloxacillin

Flucloxacillin, an antibiotic commonly used to treat bacterial infections, is the subject of several clinical trials exploring its efficacy, safety, and optimal use in various medical conditions. These studies aim to improve our understanding of how flucloxacillin works in the body and how it can be best utilized to treat infections while minimizing potential side effects.

Table of Contents

What is Flucloxacillin?

Flucloxacillin is an antibiotic medication used to treat various bacterial infections. It belongs to a class of antibiotics called penicillins, specifically the isoxazolyl penicillins. These antibiotics are designed to be resistant to breakdown by certain bacteria that have developed ways to fight off regular penicillin[1].

Flucloxacillin is also known by other names, including:

  • Floxapen
  • Fluclomix
  • Ladropen

These alternative names may be used in different countries or by different manufacturers[2].

What Conditions Does Flucloxacillin Treat?

Flucloxacillin is primarily used to treat infections caused by certain types of bacteria, especially those that have become resistant to regular penicillin. Some of the conditions it can treat include:

  • Cellulitis: An infection of the skin and underlying tissues[3]
  • Wound infections: Infections that occur in cuts, scrapes, or surgical wounds[3]
  • Abscesses: Pockets of pus that can form in various parts of the body[3]
  • Staphylococcus aureus infections: Including bloodstream infections caused by this bacteria[4]

These conditions are often referred to as “acute bacterial skin and skin structure infections” (ABSSSIs) in medical terms[3].

How is Flucloxacillin Administered?

Flucloxacillin can be given in several ways, depending on the severity of the infection and the patient’s condition:

  • Oral capsules: For less severe infections, flucloxacillin may be given as capsules to be taken by mouth. The typical dose is 500mg taken four times a day[3].
  • Intravenous (IV) infusion: For more serious infections, flucloxacillin can be given directly into a vein. This is often done in a hospital setting. The dose may vary, but it’s commonly given as 2g every 6 hours for adults[1].

The duration of treatment can vary from a few days to several weeks, depending on the type and severity of the infection[1].

Flucloxacillin Compared to Other Antibiotics

Researchers are constantly studying how flucloxacillin compares to other antibiotics in treating various infections. Some key comparisons include:

  • Flucloxacillin vs. Benzylpenicillin: Some studies are looking at whether benzylpenicillin might be more effective than flucloxacillin for certain types of Staphylococcus aureus infections[4].
  • Flucloxacillin vs. Ceftriaxone: In some cases, ceftriaxone (another type of antibiotic) may be used instead of flucloxacillin, especially for home-based treatment of cellulitis in children[1].
  • Flucloxacillin alone vs. Flucloxacillin with other antibiotics: Some research is investigating whether adding other antibiotics to flucloxacillin treatment might be more effective for certain infections[3].

Potential Side Effects

Like all medications, flucloxacillin can cause side effects in some people. Some potential side effects that are being monitored in clinical trials include:

  • Liver problems: In rare cases, flucloxacillin can affect liver function. Doctors may monitor liver enzymes during treatment[2].
  • Kidney issues: Some patients may experience changes in kidney function[2].
  • Phlebitis: This is inflammation of a vein, which can sometimes occur with IV administration[2].
  • Changes in blood cell counts: In some cases, flucloxacillin might affect the levels of certain blood cells[2].

It’s important to discuss any concerns about side effects with your healthcare provider.

Ongoing Research

Scientists are continually studying flucloxacillin to better understand its effects and improve its use. Some areas of current research include:

  • Optimal dosing: Researchers are studying the best ways to administer flucloxacillin, including dosage amounts and frequency[5].
  • Combination therapies: Studies are looking at whether combining flucloxacillin with other antibiotics might be more effective for certain infections[2].
  • Home vs. hospital treatment: Some research is comparing the effectiveness of treating certain infections with flucloxacillin at home versus in the hospital[1].
  • Effects on gut bacteria: Scientists are investigating how flucloxacillin might affect the balance of bacteria in the digestive system[1].

These ongoing studies help doctors better understand how to use flucloxacillin effectively and safely in different situations.

Aspect Details
Main Uses Treatment of bacterial infections, particularly those caused by Staphylococcus aureus, cellulitis, wound infections, and abscesses
Administration Methods Oral capsules, intravenous infusion, continuous infusion
Dosages Studied Varying from 500mg to 2g, administered 3-4 times daily or as continuous infusion
Key Outcomes Measured Clinical cure rates, reduction in infection symptoms, changes in blood markers, drug concentrations, quality of life improvements
Comparisons Benzylpenicillin, combinations with phenoxymethylpenicillin or clindamycin
Safety Monitoring Liver function, kidney injury, phlebitis, blood cell count changes
Special Investigations Enzyme induction effects, pharmacokinetics in intensive care patients
Patient Populations Adults with various bacterial infections, including those in intensive care units
Duration of Treatment Ranging from 2 to 6 weeks, depending on the severity and type of infection
Additional Considerations Cost-effectiveness analysis, adherence to medication, health-related quality of life assessments

FAQ

  • What is flucloxacillin used for in these clinical trials? Flucloxacillin is being studied for treating various bacterial infections, including cellulitis, wound infections, abscesses, and Staphylococcus aureus bloodstream infections. It's also being investigated for its potential to induce certain enzymes in the body.
  • How is flucloxacillin administered in these studies? Flucloxacillin is administered in different ways depending on the study. It can be given orally as capsules, intravenously, or as a continuous infusion. The dosage and duration of treatment vary based on the specific trial and condition being treated.
  • Are there any side effects of flucloxacillin being monitored in these trials? Yes, the trials are monitoring for various side effects. These include liver function changes, kidney injury, phlebitis (inflammation of veins), and changes in blood cell counts. The studies also look at overall safety and tolerability of the drug.
  • How does flucloxacillin compare to other antibiotics in these trials? Some trials compare flucloxacillin to other antibiotics like benzylpenicillin or combine it with drugs like phenoxymethylpenicillin or clindamycin. These comparisons help determine the most effective treatment strategies for different infections.
  • What are the main outcomes being measured in these flucloxacillin trials? The trials measure various outcomes, including clinical cure rates, reduction in infection symptoms, changes in blood markers of infection, drug concentrations in the body, quality of life improvements, and cost-effectiveness of treatment.

Ongoing Clinical Trials on Flucloxacillin

  • Study of Switching from Intravenous to Oral Antibiotics in Patients with Infective Endocarditis Using a Drug Combination

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

  • Study on the Effectiveness of Clarithromycin and Other Drug Combinations for Patients with Uncomplicated Staphylococcus aureus Blood Infection

    Recruiting

    1 1 1 1
    Investigated drugs:
    Denmark

  • Study on Optimizing Initial Dosing of Flucloxacillin and Drug Combination for Critically Ill Patients with Sepsis in the ICU

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on the Effect of Rifampicin and Drug Combination for Patients with Staphylococcus aureus Bacteremia

    Recruiting

    1 1 1 1
    Investigated drugs:
    France Germany The Netherlands Sweden

  • Comparing local gentamicin or vancomycin hydrochloride to a drug combination for patients with diabetic foot osteomyelitis

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland

Glossary

  • Flucloxacillin: An antibiotic medication used to treat bacterial infections, particularly those caused by Staphylococcus aureus.
  • Cellulitis: A common bacterial skin infection that causes redness, swelling, and pain in the affected area.
  • Staphylococcus aureus: A type of bacteria that can cause various infections, ranging from skin infections to more serious conditions like bloodstream infections.
  • Bacteraemia: The presence of bacteria in the bloodstream, which can lead to serious infections throughout the body.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • CYP enzymes: A group of enzymes in the body that play a crucial role in metabolizing drugs and other substances.
  • Intravenous (IV): A method of administering medication directly into a vein.
  • Bioavailability: The proportion of a drug that enters the circulation when introduced into the body and is able to have an active effect.
  • Adverse event: Any unfavorable and unintended sign, symptom, or disease temporarily associated with the use of a medical treatment or procedure.
  • Randomized controlled trial: A type of scientific experiment where participants are randomly assigned to different treatment groups to compare the effects of different interventions.

References

  1. https://clinicaltrials.gov/study/NCT02334124
  2. https://clinicaltrials.gov/study/NCT01876628
  3. https://clinicaltrials.gov/study/NCT02922686
  4. https://clinicaltrials.gov/study/NCT03632642
  5. https://clinicaltrials.gov/study/NCT00358371